Oracle (NYSE:ORCL) was in focus on Thursday as investment firm Argus raised its earnings estimates and upgraded the IT tech giant after it reported fiscal third-quarter results. Shares were flat in ...

Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research ...

Argus analyst Joseph Bonner raised the firm’s price target on Oracle (ORCL) to $200 from $176 and keeps a Buy rating on the shares after its Q2 results. The company is in the enviable position of ...

These two software modules provide a state-of-the-art technology backbone and cleaner interface in addition to strong redundancy and an efficient configurable workflow for Synteract's clients. Key ...

To help clinical trial sponsors and contract research organizations (CROs) more cost-effectively and efficiently capture and manage information on adverse events, Oracle has integrated Oracle Health ...

Oracle Corporation (NYSE:ORCL) shares are trading lower on Friday. On Thursday, the company unveiled Exadata Exascale, a cloud-based data architecture enhancing performance for Oracle Database ...

The FINANCIAL — Oracle Health Sciences on June 16 announced the availability of Oracle Argus Standard Edition 8.0, Oracle Argus Enterprise Edition 8.0, and Oracle Argus Safety Japan 8.0—major new ...

PRINCETON, N.J., March 28, 2019 /PRNewswire-PRWeb/ -- Established in 1945, Daewoong Pharmaceutical is a leading South Korean pharmaceutical company that has developed, manufactured, and commercialized ...

NEW DELHI--(BUSINESS WIRE)--APCER Life Sciences, the preferred pharmacovigilance (PV) services provider for pharmaceutical and biotech companies seeking compliance and safety management solutions ...

SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Synteract, a leading full service contract research organization (CRO), has implemented two Oracle® Argus 7.0 modules to its pharmacovigilance technology ...